On March 9, 2020, the Federal Trade Commission and the Food and Drug Administration will co-sponsor a public workshop on promoting competition in biologics markets. The workshop will be held at the FDA’s White Oak Campus in Silver Spring, Maryland and will also be webcast.
Workshop panelists will discuss the agencies’ efforts to support competition between biosimilars and reference biologics, discouraging false or misleading statements about biosimilars’ safety and efficacy, and deterring anti-competitive behaviors in the biologic marketplace. Last month, the FTC and the FDA signed a joint statement promoting competition in markets for biologics.
For more information about viewing the webcast, and for background information on the event, see the FDA’s meeting announcement. All available tickets for onsite seating are reserved, but registration for the webcast is still available. The webcast will also be archived for later viewing.
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Sign me up for the newsletter!
Notify me of follow-up comments by email.
Notify me of new posts by email.
UK Government announces £10 million for small businesses to kickstart tourism
Aditya Birla Sun Life Insurance launches Child’s Future Assured Plan
Andy Edwards appointed Springboks new Head of Athletic Performance
Sonalika records 55% growth in domestic volume in June’20. Outpaces industry growth at 23%
Liberty General Insurance Introduces ‘Liberty Assure’ –
2014 The Global Indian New Network (TGINN)